Although we did not find significant association between different GSTP1 haplotypes and the CAD-related HF risk, the obvious trend for decreasing HF risk in carriers of the GSTP1∗C (Val105/Val114) haplotype might have a molecular explanation in its ability to prevent apoptosis more efficiently. The gene discussed is GSTP1; the disease is coronary artery disorder.